A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Clinical trial NCT07366034 · RECRUITING
Trial details
- NCT number
- NCT07366034
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2029-04-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.